The genito urinary cancer group at The Christie is one of the most advanced urological cancer teams in the country.
Patients are managed in a multi-disciplinary setting and the service incorporates both in-patient and out-patient facilities. This multi-disciplinary group combines specialist urological cancer surgeons with uroradiotherapists, specialist medical oncologists, urological cancer nurses and a comprehensive research team for the management of all urological cancers and for research into genito-urinary malignancy.
There is specific expertise for dealing with conventional and complex kidney (renal), bladder, prostate, penile and testicular cancers and published outcomes from treatment are amongst the best in the UK. All modalities of treatment are available for these cancer types and since January 2008, the Da Vinci operating robot has been in service for the treatment of localised prostate cancer using robotic techniques. The Team have the most advanced Robotic service in the North West, having operated on nearly 1000 patients.
In addition to this, the urological team is a key member of the integrated Christie "Pelvic Team". This multi-disciplinary group provides advanced surgical expertise for the diagnosis and treatment for patients with ultra-complex or advanced pelvic tumours of both gynaecological, large bowel and sarcomatous origin.
The Team has expertise in survivorship issues, having expertise in managing urological side effects of surgery, radiotherapy and chemotherapy. This includes obstructed kidneys, urinary fistulae and incontinence, and erectile dysfunction.
The team accepts referrals from local, regional, national and international sources.